Search Results - "Wills, G. H."

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study by Murphy, M E, Wills, G H, Murthy, S, Louw, C, Bateson, A L C, Hunt, R D, McHugh, T D, Nunn, A J, Meredith, S K, Mendel, C M, Spigelman, M, Crook, A M, Gillespie, S H

“…In the REMoxTB study of 4-month treatment-shortening regimens containing moxifloxacin compared to the standard 6-month regimen for tuberculosis, the proportion…”
Get full text

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts by Oelofse, S., Esmail, A., Diacon, A. H., Conradie, F., Olayanju, O., Ngubane, N., Howell, P., Everitt, D., Crook, A. M., Mendel, C. M., Wills, G. H., Olugbosi, M., del Parigi, A., Sun, E., Calatroni, A., Spigelman, M., Dheda, K.

“…BACKGROUND: There are no data comparing the 6-9 month oral three-drug Nix regimen (bedaquiline, pretomanid and linezolid [BPaL]) to conventional regimens…”
Get full text

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB by Tweed, C. D., Wills, G. H., Crook, A. M., Amukoye, E., Balanag, V., Ban, A. Y.L., Bateson, A. L.C., Betteridge, M. C., Brumskine, W., Caoili, J., Chaisson, R. E., Cevik, M., Conradie, F., Dawson, R., del Parigi, A., Diacon, A., Everitt, D. E., Fabiane, S.M., Hunt, R., Ismail, A. I., Lalloo, U., Lombard, L., Louw, C., Malahleha, M., McHugh, T. D., Mendel, C. M., Mhimbira, F., Moodliar, R. N., Nduba, V., Nunn, A. J., Sabi, I., Sebe, M. A., Selepe, R. A. P., Staples, S., Swindells, S., van Niekerk, C. H., Variava, E., Spigelman, M., Gillespie, S. H.

“…BACKGROUND: Treatment for TB is lengthy and toxic, and new regimens are needed.METHODS: Participants with pulmonary drug-susceptible TB (DS-TB) were randomised…”
Get full text

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis by Conradie, Francesca, Bagdasaryan, Tatevik R., Borisov, Sergey, Howell, Pauline, Mikiashvili, Lali, Ngubane, Nosipho, Samoilova, Anastasia, Skornykova, Sergey, Tudor, Elena, Variava, Ebrahim, Yablonskiy, Petr, Everitt, Daniel, Wills, Genevieve H., Sun, Eugene, Olugbosi, Morounfolu, Egizi, Erica, Li, Mengchun, Holsta, Alda, Timm, Juliano, Bateson, Anna, Crook, Angela M., Fabiane, Stella M., Hunt, Robert, McHugh, Timothy D., Tweed, Conor D., Foraida, Salah, Mendel, Carl M., Spigelman, Melvin

“…A randomized trial of bedaquiline–pretomanid–linezolid for highly drug-resistant tuberculosis assessed the use of linezolid at 600 or 1200 mg for 9 or 26…”
Get full text

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children by Turkova, Anna, Wills, Genevieve H., Wobudeya, Eric, Chabala, Chishala, Palmer, Megan, Kinikar, Aarti, Hissar, Syed, Choo, Louise, Musoke, Philippa, Mulenga, Veronica, Mave, Vidya, Joseph, Bency, LeBeau, Kristen, Thomason, Margaret J., Mboizi, Robert B., Kapasa, Monica, van der Zalm, Marieke M., Raichur, Priyanka, Bhavani, Perumal K., McIlleron, Helen, Demers, Anne-Marie, Aarnoutse, Rob, Love-Koh, James, Seddon, James A., Welch, Steven B., Graham, Stephen M., Hesseling, Anneke C., Gibb, Diana M., Crook, Angela M.

“…Completing 6 months of treatment for tuberculosis in children is a challenge. In this open-label trial involving 1204 children in sub-Saharan Africa and India,…”
Get full text